Rank 64 • MedTech & Devices
Synchron
Develops endovascular brain-computer interfaces implanted via the blood vessels to restore motor function.
Visit website- Signal Score
- 84.7
- Total raised
- $145M
- Stage
- Series C
- Founded
- 2016
- Headquarters
- Brooklyn, USA
- Region
- North America
Their signal
Competes with Neuralink using a safer, minimally invasive endovascular delivery method that avoids open-brain surgery, backed by key clinical trials and major tech-pioneer investors.
Signal Score 84.7editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.